Syra Health Corp. SYRA
$0.91
$0.022.25%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.32% | 31.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.32% | 31.11% | |||
| Cost of Revenue | 1.98% | 13.95% | |||
| Gross Profit | 9.78% | 64.29% | |||
| SG&A Expenses | -0.74% | 6.61% | |||
| Depreciation & Amortization | -36.36% | -52.17% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.90% | 11.38% | |||
| Operating Income | 31.73% | 240.75% | |||
| Income Before Tax | 3.82% | 279.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.82% | 279.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.82% | 279.05% | |||
| EBIT | 31.73% | 240.75% | |||
| EBITDA | 37.14% | 247.35% | |||
| EPS Basic | -5.94% | 278.76% | |||
| Normalized Basic EPS | -5.56% | 280.00% | |||
| EPS Diluted | -5.00% | 276.99% | |||
| Normalized Diluted EPS | -2.54% | 268.57% | |||
| Average Basic Shares Outstanding | 10.35% | -0.01% | |||
| Average Diluted Shares Outstanding | 6.03% | 7.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||